Hisam Siddiqi: Understanding Bone Marrow Trephine Morphology in MPNs
Hisam Siddiqi, Consultant Haematologist at LycaHealth, The Blackheath Hospital, Dartford and Gravesham NHS Trust, shared a post on LinkedIn:
“Understanding Bone Marrow Trephine Morphology in MPNs – A Simple Breakdown
Myeloproliferative neoplasms (MPNs) can often look similar clinically, but the bone marrow trephine provides important clues that help us distinguish between them.
Here’s a quick, simplified guide to typical findings across the main MPN subtypes, based on key features: cellularity, megakaryocyte morphology, clustering patterns, and reticulin fibrosis.
Polycythaemia Vera (PRV)
- Cellularity: Very high (panmyelosis – all cell lines increased)
- Megakaryocytes: Mildly increased
- Clusters: Usually absent
- Reticulin: Normal or slightly up
- Think: a busy marrow with everything ‘turned up.’
Essential Thrombocythaemia (ET)
- Cellularity: Normal
- Megakaryocytes: Markedly increased, hyperlobulated (‘staghorn’)
- Clusters: None or loose
- Reticulin: Normal or slightly up
- Think: lots of large, mature megakaryocytes with big, multilobed nuclei.
Pre‑Fibrotic Myelofibrosis (pre‑MF)
- Cellularity: Increased
- Megakaryocytes: Variable up; abnormally shaped, atypical, hypolobulated
- Clusters: Small, dense or loose
- Reticulin: Mildly up
- Think: dysplastic megakaryocytes plus early scarring.
Overt Myelofibrosis (MF)
- Cellularity: Often reduced
- Megakaryocytes: Increased, hypolobulated / atypical
- Clusters: Dense, tight clusters
- Reticulin: Marked fibrosis with collagen deposition
- Think: fibrotic, scarred marrow with abnormal megakaryocyte clusters.
Why this matters:
Trephine morphology remains central to accurate MPN diagnosis and helps guide prognosis and treatment decisions. Recognising these hallmark patterns can refine our diagnostic confidence and improve patient care.”

More posts featuring Hisam Siddiqi on Hemostasis Today.
-
Aug 26, 2026, 17:46Bruno Pougault: The Hidden Burden of Hemostatic Disorders in Women
-
Aug 26, 2026, 17:39Charan Gubba: Adult ITP – A major shift in the 2026 ASH Guidelines
-
Aug 26, 2026, 17:38Stephan A Mayer: Early Imaging Reveals Higher Risk of Hematoma Expansion After ICH
-
Aug 26, 2026, 17:09Kemal Karaagac: NOACs May Offer Cognitive and Clinical Benefits in AF With Alzheimer’s Disease
-
Aug 26, 2026, 16:53Chokri Ben Lamine: Antiphospholipid Syndrome After Kidney Transplantation
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation
-
Aug 26, 2026, 16:18Sam Mbunya: Celebrating Cyrus Njuguna Githinji’s New Leadership Role in Haemophilia Care
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”